At present, there are no disease-modifying treatments to stall the progression of Parkinson’s disease (PD). A drug in development to treat diabetes might provide a way to slow it down. The drug, MSDC-0160, targets a recently identified carrier of pyruvate (a major substrate for energy production) into mitochondria . Ghosh et al. successfully used the drug to block neurodegeneration in several different cellular and animal models of PD. Furthermore, in two mouse models of PD, cellular autophagy was restored and neuroinflammation was reduced.focuz.ru
Orla M. Smith
Want To Publish your Group Article?
Click HERE to send us your group Article for publishing on our website.
- alzheimer Alzheimers Disease animal model antibiotic resistance antibiotics Bacteria Brain breast cancer cancer cell-signaling clinical trials CRISPR diabetes disease/medicine DNA drug drug research Gene Expression general health Gene therapy Genetics genetics & genomics Genomics HIV immunology immunotherapy infectious disease Malaria microbiology microbiome mutation neuroscience new therapy obesity Parkinson's disease stem cells T cells techniques therapy treatment tumor vaccine virology virus Zika virus